T

Tempus AI Inc
NASDAQ:TEM

Watchlist Manager
Tempus AI Inc
NASDAQ:TEM
Watchlist
Price: 58.6 USD 11.66% Market Closed
Market Cap: 9.2B USD
Have any thoughts about
Tempus AI Inc?
Write Note

Net Margin
Tempus AI Inc

-109.5%
Current
-109%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-109.5%
=
Net Income
-923.4m
/
Revenue
843.6m

Net Margin Across Competitors

Country US
Market Cap 9B USD
Net Margin
-109%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 196.3B USD
Net Margin
14%
Country US
Market Cap 170.3B USD
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
22%
Country US
Market Cap 36.7B USD
Net Margin
9%
Country US
Market Cap 26.4B USD
Net Margin
21%
Country US
Market Cap 23B USD
Net Margin
17%
Country US
Market Cap 22.3B USD
Net Margin
-36%
No Stocks Found

Tempus AI Inc
Glance View

Market Cap
9B USD
Industry
Life Sciences Tools & Services

Tempus AI Inc. is revolutionizing the landscape of healthcare by leveraging cutting-edge artificial intelligence to enhance patient care and outcomes. Founded in 2015, the company has focused on integrating advanced data analytics and machine learning technologies to curate personalized treatment plans in oncology and beyond. Their innovative platform aggregates clinical and molecular data, allowing healthcare professionals to make informed decisions based on the latest research and patient-specific information. By partnering with leading healthcare institutions, Tempus is transforming the way physicians approach diagnosis and treatment, ultimately driving a more precise and effective healthcare system. For investors, Tempus represents a compelling opportunity in the rapidly growing health tech sector, especially as demands for personalized medicine continue to rise. The company's robust technology, combined with a strong leadership team and strategic partnerships, positions it as a frontrunner in data-driven healthcare solutions. Tempus has already demonstrated significant traction, evidenced by its expanding clientele and investment from prominent venture capital firms. With a commitment to enhancing patient outcomes and reducing healthcare costs, Tempus AI Inc. is not only shaping the future of medicine but also presenting a promising opportunity for those looking to invest in the intersection of technology and health.

TEM Intrinsic Value
47.39 USD
Overvaluation 19%
Intrinsic Value
Price
T

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-109.5%
=
Net Income
-923.4m
/
Revenue
843.6m
What is the Net Margin of Tempus AI Inc?

Based on Tempus AI Inc's most recent financial statements, the company has Net Margin of -109.5%.